Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 229 results.
User Information
Export Records
  1. 1.   HIV-1 cores retain their integrity until minutes before uncoating in the nucleus
  2. Li,Chenglei; Burdick,Ryan; Nagashima,Kunio; Hu,Wei-Shau; Pathak,Vinay
  3. Proceedings of the National Academy of Sciences of the United States of America. 2021, Mar 09; 118(10):
  1. 2.   Nuclear Import of the HIV-1 Core Precedes Reverse Transcription and Uncoating
  2. Selyutina, Anastasia; Persaud, Mirjana; Lee,Kyeongeun; KewalRamani,Vineet; Diaz-Griffero, Felipe
  3. Cell reports. 2020, Sep 29; 32(13): 108201.
  1. 3.   Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle
  2. Novikova, Mariia; Zhang, Yulan; Freed,Eric; Peng, Ke
  3. Virologica Sinica. 2019, APR; 34(2): 119-134.
  1. 4.   The origin of exotic pet sugar gliders (Petaurus breviceps) kept in the United States of America
  2. Campbell, Catriona D.; Pecon-Slattery, Jill; Pollak, Rebecca; Joseph, Leo; Holleley, Clare E.
  3. PEERJ. 2019, Jan 8; 7
  1. 5.   HIV-1 Capsid-Targeting Domain of Cleavage and Polyadenylation Specificity Factor 6
  2. Lee, K.; Mulky, A.; Yuen, W.; Martin, T. D.; Meyerson, N. R.; Choi, L.; Yu, H.; Sawyer, S. L.; KewalRamani, V. N.
  3. Journal of Virology. 2012, Apr; 86(7): 3851-3860.
  1. 6.   HECT and RING finger families of E3 ubiquitin ligases at a glance
  2. Metzger, M. B.; Hristova, V. A.; Weissman, A. M.
  3. Journal of Cell Science. 2012, Feb; 125(3): 531-537.
  1. 7.   The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation
  2. Weissman, A. M.; Shabek, N.; Ciechanover, A.
  3. Nature Reviews Molecular Cell Biology. 2011, Sep; 12(9): 605-620.
  1. 8.   Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
  2. Kuhns, D. B.; Alvord, W. G.; Heller, T.; Feld, J. J.; Pike, K. M.; Marciano, B. E.; Uzel, G.; DeRavin, S. S.; Priel, D. A. L.; Soule, B. P.; Zarember, K. A.; Malech, H. L.; Holland, S. M.; Gallin, J. I.
  3. New England Journal of Medicine. 2010, Dec; 363(27): 2600-2610.
  1. 9.   Generation of HIV-1 primary isolates representative of plasma variants using the U87.CD4 cell line
  2. Heeregrave, E. J.; Ampofo, W. K.; Tetteh, J. K. A.; Ofori, M.; Ofori, S. B.; Shah, A. S.; Pollakis, G.; Paxton, W. A.
  3. Journal of Virological Methods. 2010, Nov; 169(2): 341-350.
  1. 10.   Genetic introgression and the survival of Florida panther kittens
  2. Hostetler, J. A.; Onorato, D. P.; Nichols, J. D.; Johnson, W. E.; Roelke, M. E.; O'Brien, S. J.; Jansen, D.; Oli, M. K.
  3. Biological Conservation. 2010, Nov; 143(11): 2789-2796.
  1. 11.   CCAAT/enhancer binding protein delta (C/EBP delta, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage
  2. Wang, J.; Sarkar, T. R.; Zhou, M.; Sharan, S.; Ritt, D. A.; Veenstra, T. D.; Morrison, D. K.; Huang, A. M.; Sterneck, E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Sep; 107(37): 16131-16136.
  1. 12.   Reverse transcriptase in motion: Conformational dynamics of enzyme-substrate interactions
  2. Gotte, M.; Rausch, J. W.; March, B.; Sarafianos, S.; Le Grice, S. F. J.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2010, May; 1804(5): 1202-1212.
  1. 13.   Targeting and Insertion of the Cholesterol-Binding Translocator Protein into the Outer Mitochondrial Membrane
  2. Rone, M. B.; Liu, J.; Blonder, J.; Ye, X. Y.; Veenstra, T. D.; Young, J. C.; Papadopoulos, V.
  3. Biochemistry. 2009 48(29): 6909-6920.
  1. 14.   Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry
  2. Yu, K. J.; Bashirova, A.; Madeleine, M. M.; Cheng, J.; Johnson, L. G.; Schwartz, S. M.; Carrington, M.; Hildesheim, A.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Nov; 16(11): 2504-2508.
  1. 15.   Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis
  2. Thomas, D. C.; Voronin, Y. A.; Nikolenko, G. N.; Chen, J. B.; Hu, W. S.; Pathak, V. K.
  3. Journal of Virology. 2007, May; 81(9): 4798-4807.
  1. 16.   In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity
  2. Jones, F. D.; Hughes, S. H.
  3. Virology. 2007, Apr; 360(2): 341-349.
  1. 17.   Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis
  2. Rausch, J. W.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2007, Jan; 35(1): 256-268.
  1. 18.   Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms
  2. Pu, Y. M.; Peach, M. L.; Garfield, S. H.; Wincovitch, S.; Marquez, V. E.; Blumberg, P. M.
  3. Journal of Biological Chemistry. 2006, Nov; 281(44): 33773-33788.
  1. 19.   Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer
  2. Pithukpakorn, M.; Wei, M. H.; Toure, O.; Steinbach, P. J.; Glenn, G. M.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, Sep; 43(9): 755-762.
  1. 20.   Mining the NCI antiviral compounds for HIV-1 integrase inhibitors
  2. Deng, J. X.; Kelley, J. A.; Barchi, J. J.; Sanchez, T.; Dayam, R.; Pommier, Y.; Neamati, N.
  3. Bioorganic & Medicinal Chemistry. 2006, JUN 1; 14(11): 3785-3792.
  1. 21.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 22.   Asymmetric localization of Vangl2 and Fz3 indicate novel mechanisms for planar cell polarity in mammals
  2. Montcouquiol, M.; Sans, N.; Huss, D.; Kach, J.; Dickman, J. D.; Forge, A.; Rachel, R. A.; Copeland, N. G.; Jenkins, N. A.; Bogani, D.; Murdoch, J.; Warchol, M. E.; Wenthold, R. J.; Kelley, M. W.
  3. Journal of Neuroscience. 2006, MAY 10; 26(19): 5265-5275.
  1. 23.   Meeting report: Exploiting the Tumor Microenvironment for Therapeutics
  2. Melillo, G.; Semenza, G. L.
  3. Cancer Research. 2006, MAY 1; 66(9): 4558-4560.
  1. 24.   Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization
  2. McWilliams, M. J.; Julias, J. G.; Sarafianos, S. G.; Alvord, W. G.; Arnold, E.; Hughes, S. H.
  3. Virology. 2006, May; 348(2): 378-388.
  1. 25.   Prelamin A and lamin A appear to be dispensable in the nuclear lamina
  2. Fong, L. G.; Ng, J. K.; Lammerding, J.; Vickers, T. A.; Meta, M.; Cote, N.; Gavino, B.; Qiao, X.; Chang, S. Y.; Young, S. R.; Yang, S. H.; Stewart, C. L.; Lee, R. T.; Bennett, C. F.; Bergo, M. O.; Young, S. G.
  3. Journal of Clinical Investigation. 2006, MAR; 116(3): 743-752.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel